NJ ACTS in the NEWS

Reynold Panettieri and Marila Gennaro

Named Fellows of the American Association

for the Advancement of Science

The NJ ACTS Community congratulates both on this prestigious and well-deserved honor.

Reynold Panettieri Jr., MD, Vice Chancellor for Translational Medicine and Science and Director, Rutgers Institute for Translational Medicine and Science and Professor of Medicine, Robert Wood Johnson Medical School, was named for distinguished contributions to the basic science of pulmonary disease and inflammation and for outstanding leadership of the Rutgers Clinical and Translational Science Awards Program. 

Maria Laura Gennaro, MD, Professor, Department of Medicine, Rutgers New Jersey Medical School, and Professor, Department of Epidemiology and Biostatistics, Rutgers School of Public Health, was named for outstanding contributions to understanding host/pathogen interactions, including Mycobacterium tuberculosis and SARS-CoV-2. 

Read the Full Article

Dr. Panettieri is the Director of NJ ACTS.

Dr. Gennaro is the Lead for NJ ACTS Biomarkers.

Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events

Find out what impact your research or innovation could have in solving real-world problems

Transform your technology into

benefits for society

Hosted by Princeton -Virtual

May 5, 13, and 26

Clinical Trials Day 2026

Advancing Health Through Research

Join us in celebrating the vital role of clinical research professionals and shining a light on the next generation of the translational science workforce

At Princeton Innovation Conference at Reunions join hundreds of founders, fuelers, and funders who are translating technologies from idea to impact in AI, arts and humanities, biotech and life sciences, deep tech, education and edtech, energy and the environment, fintech, social enterprise–and more.

Funding Available

Integrated Population Health Data Project



The iPHD aims to improve the health, safety, security, and well-being of New Jersey residents, as well as the efficiency of state government, by securely linking administrative datasets to support approved research projects.

Limited funding will be available to support up to two (2) full or partial waivers (up to $25,000) of data fees in each 2026 Cycle of the iPHD Project. 

CTSA News and Events

NCATS, NIH, and Federal News and Events

Earn your ACTS Digital Badge

ACTS is currently offering new Digital Badges for Team Science Fundamentals and Team Science Practitioner.

This webinar will explore how decentralized pragmatic studies and learning health systems can work together to accelerate the evaluation, implementation, and refinement of digital health technologies.

Are you interested in bringing patient stories into your research and using rigorous, team-based, qualitative methods? Join us for our annual Health Experiences Research Network (HERN) training, hosted by the University of New Mexico.

How large-scale data can be leveraged to address critical challenges in global genomics, medicine and population health. Read More

NJ ACTS Publication Highlights

Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19. Stephen J. Balevic, MD, PhD; Daniel K. Benjamin Jr, MD, PhD; William G. Powderly, MD; et al. JAMA Network Open. 2024 Apr; 7(4): e247615. Published online 2024 Apr 25. 

doi: 10.1001/jamanetworkopen.2024.7615

Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis. Kyoko Saito, Avinash Gabbeta, Evan Mulvihill, Lina Al-Jaberi, Timothy Beukelman, James D. Lewis, Carlos D. Rose, Brian L. Strom, Daniel B. Horton. Pharmacoepidemiology & Drug Safety. 29 April 2024. 

https://doi.org/10.1002/pds.5803

ICYMI

Wildfires and Their Impacts on the Environment and Health - May 6th, 9 am - 5 pm. Flyer and Register

Element B

Administration

Element C1

Workforce Development

Element C2

Community & Stakeholder Engagement

Element D1

*Biostatistics, Epidemiology &

Research Design (BERD)

*Team Science

*Regulatory Knowledge & Support

*Special Populations in Research

*Biomarkers

*Genetically informed Research

Education & Training (GREAT)

*Clinical Trials Office

Element D2

Clinical & Translational Science Pilots

Element D3

Clinical Informatics

Element E1

Clinical & Translational Science Research: Novel Genetic Services Model

Element E2

Clinical & Translational Science Research: Translating Evidence on Opioid Overdose

Training Programs

*Mentored Career Development DEVELOP (K12)

*Predoctoral Training ASCENT (T32)

*Short-Term Research CREST (R25)

Working Groups

*Health Policy in Action

*Dissemination & Implementation Science

*Team Science

*Learning Health System

*Engagement for Impact

This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UM1TR004789 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.

New Jersey Alliance for Clinical and Translational Science

89 French St., Suite 4211

New Brunswick, NJ

Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved

Send story ideas to NJACTS@rbhs.rutgers.edu

UL1TR003017 (pre-5/1/2024), UM1TR004789 (starting 5/1/2024), KL2TR003018 and TL1TR003019 (pre-5/1/2024), K12TR004788(starting 7/1/2024), T32TR004782 (starting 9/1/2024), R25TR004777 (starting 9/1/2024)